Gene · 54578
Papers1,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic and Immunological Roles of CES2 in Breast Cancer and Potential Application of CES2-Targeted Fluorescent Probe DDAB in Breast Surgery. | Int J Gen Med | 2023 | 37139258 | PubTator, text mining | PubMed |
| Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity. | Sci Adv | 2023 | 37126556 | PubTator, text mining | PubMed |
| Ontogeny of CYP3A and UGT activity in preterm piglets: a translational model for drug metabolism in preterm newborns. | Front Pharmacol | 2023 | 37124224 | PubTator, text mining | PubMed |
| Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns. | Pharmaceutics | 2023 | 37111637 | PubTator, text mining | PubMed |
| In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein. | Pharmaceutics | 2023 | 37111580 | PubTator, text mining | PubMed |
| Colorectal Cancer Chemoprevention: A Dream Coming True? | Int J Mol Sci | 2023 | 37108756 | PubTator, text mining | PubMed |
| A novel pyroptosis-related model for prognostic prediction in esophageal squamous cell carcinoma: a bioinformatics analysis. | J Thorac Dis | 2023 | 37065557 | PubTator, text mining | PubMed |
| Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma. | J Cancer | 2023 | 37056387 | PubTator, text mining | PubMed |
| Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants. | Biomedicines | 2023 | 36979919 | PubTator, text mining | PubMed |
| A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid. | Saudi Pharm J | 2023 | 36942277 | PubTator, text mining | PubMed |
| In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer. | Sci Rep | 2023 | 36927770 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? | Int J Mol Sci | 2023 | 36901856 | PubTator, text mining | PubMed |
| Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning. | Sci Rep | 2023 | 36882493 | PubTator, text mining | PubMed |
| Bioinformatic analysis of the obesity paradox and possible associated factors in colorectal cancer using TCGA cohorts. | J Cancer | 2023 | 36860923 | PubTator, text mining | PubMed |
| Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast. | Biomedicines | 2023 | 36830817 | PubTator, text mining | PubMed |
| Distilling functional variations for human UGT2B4 upstream region based on selection signals and implications for phenotypes of Neanderthal and Denisovan. | Sci Rep | 2023 | 36823244 | PubTator, text mining | PubMed |
| Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. | J Natl Med Assoc | 2023 | 36801148 | PubTator, text mining | PubMed |
| Biotransformation of Penindolone, an Influenza A Virus Inhibitor. | Molecules | 2023 | 36771146 | PubTator, text mining | PubMed |
| Herb-drug interaction of Xingnaojing injection and Edaravone via pharmacokinetics, mixed inhibition of UGTs, and molecular docking. | Phytomedicine | 2023 | 36764095 | PubTator, text mining | PubMed |
| Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials. | Clin Transl Sci | 2023 | 36752279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54578/papers?page=7